The Traderszone Network

Published in TZ Latest News 19 August, 2014 by The TZ Newswire Staff

Allergan seeks deal with Salix to fend off Valeant: WSJ

Allergan and Salix declined to comment on the matter. Shares of Salix, which itself is in the process of merging with a unit of Swiss-listed Cosmo Pharmaceuticals, jumped about 10 percent on Tuesday. It isn’t clear where any talks with Salix stand, but one of the sources said Allergan could strike a takeover deal with the company or another unknown party as early as next month, Journal said.